Amerant Bancorp officer exercises RSUs, withholds shares

Amerant Bancorp Inc. officer Michael E. Nursey reported equity award activity involving restricted stock units and Class A common stock.

Rhea-AI Filing Summary

Amerant Bancorp Inc. officer Michael E. Nursey reported equity award activity involving restricted stock units and Class A common stock. On February 18, 2026, he exercised 666 restricted stock units labeled “Restricted Stock Units LTI 2025,” receiving 666 shares of Class A common stock at $0.00 per share.

On the same date, 187 shares of Class A common stock at $22.38 per share were surrendered to cover tax withholding obligations upon RSU vesting, leaving him with 1,494 Class A shares directly owned after these transactions. Footnotes state each RSU is economically equivalent to one Class A share and reference a prior 2,000 RSU award granted on February 18, 2025 that vests in three annual installments, subject to continued service.

Insider Trade Summary

666 shares exercised/converted

Exercise 3 txns

Insider Nursey Michael E.

Role See remarks

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units LTI 2025	666	$0.00	$0.00
Exercise	Class A Common Stock	666	$0.00	$0.00
Exercise Price or Tax Liability	Class A Common Stock	187	$22.38	$4K

Holdings After Transaction: Restricted Stock Units LTI 2025 — 1,334 contracts (Direct); Class A Common Stock — 1,494 shares (Direct)

Footnotes (3)

1. F1. Each RSU is the economic equivalent of one share of Class A Common Stock.
2. F2. Reflects the shares of Class A Common Stock that were surrendered in order to satisfy the reporting person's tax withholding obligation upon the vesting of RSUs.
3. F3. On February 18, 2025, Mr. Nursey was awarded 2,000 RSUs each representing the right to receive, following vesting, one share of Class A Common Stock. The award vests in substantially equal installments on each of the first three anniversaries of the date of grant, provided that Mr. Nursey remains in the continuous service of the Company or a subsidiary through each such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AMTB officer Michael Nursey report?

Michael E. Nursey reported exercising 666 restricted stock units into 666 shares of Amerant Bancorp Class A Common Stock, and surrendering 187 shares to cover tax withholding obligations. These transactions reflect equity award vesting rather than an open-market stock purchase or sale.

How many Amerant Bancorp (AMTB) RSUs did Michael Nursey exercise?

He exercised 666 restricted stock units labeled Restricted Stock Units LTI 2025, converting them into 666 shares of Class A common stock at $0.00 per share. Each RSU is economically equivalent to one Class A share, according to the filing’s footnotes.

Why were 187 AMTB shares surrendered by Michael Nursey?

The filing states 187 shares of Amerant Bancorp Class A Common Stock were surrendered to satisfy tax withholding obligations upon the vesting of RSUs. This tax-withholding disposition (coded “F”) is a common administrative step, not an open-market sale for investment purposes.

How many Amerant Bancorp (AMTB) shares does Michael Nursey own after these transactions?

After these transactions, Michael E. Nursey directly owns 1,494 shares of Amerant Bancorp Class A common stock. The filing lists this post-transaction amount following the 666-share RSU conversion and the 187-share tax-withholding disposition on February 18, 2026.

What are the terms of Michael Nursey’s 2,000 AMTB RSU award?

A footnote explains that on February 18, 2025, Mr. Nursey was awarded 2,000 RSUs, each representing one Class A share after vesting. The award vests in substantially equal installments on each of the first three anniversaries, contingent on his continuous service.

Is Michael Nursey’s Form 4 for AMTB a stock sale or tax withholding?

The Form 4 primarily reflects RSU vesting and conversion plus tax withholding. It includes an RSU exercise (code M) into 666 shares and a tax-withholding disposition (code F) of 187 shares, rather than a discretionary open-market sale or purchase of Amerant Bancorp stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 06:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nursey Michael E.

(Last) (First) (Middle)

C/O AMERANT BANCORP INC.

220 ALHAMBRA CR., 12TH FLOOR

(Street)

CORAL GABLES FL 33134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amerant Bancorp Inc. [ AMTB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/18/2026		M		666	A	$0(1)	1,681	D
Class A Common Stock	02/18/2026		F		187(2)	D	$22.38	1,494	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units LTI 2025	$0(1)	02/18/2026		M			666	(3)	(3)	Class A Common Stock	666	$0	1,334	D

Explanation of Responses:

1. Each RSU is the economic equivalent of one share of Class A Common Stock.

2. Reflects the shares of Class A Common Stock that were surrendered in order to satisfy the reporting person's tax withholding obligation upon the vesting of RSUs.

3. On February 18, 2025, Mr. Nursey was awarded 2,000 RSUs each representing the right to receive, following vesting, one share of Class A Common Stock. The award vests in substantially equal installments on each of the first three anniversaries of the date of grant, provided that Mr. Nursey remains in the continuous service of the Company or a subsidiary through each such date.

Remarks:

	/s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.